D Mason

Summary

Affiliation: University of Oxford
Country: UK

Publications

  1. ncbi request reprint CD antigens 2001
    D Mason
    Haematology Department, John Radcliffe Hospital, Oxford, UK
    J Leukoc Biol 70:685-90. 2001
  2. ncbi request reprint CD antigens 2001
    D Y Mason
    Haematology Department, Nuffield Dept of Clinical Laboratory Sciences, University of Oxford, Rm 4734 John Radcliffe Hospital, Oxford OX3 9DU, UK
    Tissue Antigens 58:425-30. 2001
  3. ncbi request reprint Innovations in immunohistochemistry for the haematopathologist
    D Y Mason
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Ann Pathol 27:1S33-6. 2007
  4. ncbi request reprint Reference: CD Antigens 2002
    David Mason
    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Immunol 168:2083-6. 2002
  5. ncbi request reprint CD Antigens 2001
    David Mason
    Haematology Department, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
    Mod Pathol 15:71-6. 2002
  6. ncbi request reprint Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
    Giovanna Roncador
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre, Madrid, Spain
    Haematologica 92:1059-66. 2007
  7. ncbi request reprint CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations
    L A Stephens
    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    J Immunol 165:3105-10. 2000
  8. pmc Peripheral autoantigen induces regulatory T cells that prevent autoimmunity
    B Seddon
    Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom
    J Exp Med 189:877-82. 1999
  9. pmc Lymphocyte-specific protein 1: a specific marker of human leucocytes
    K Pulford
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Oxford, UK
    Immunology 96:262-71. 1999
  10. ncbi request reprint Expression of TAL-1 proteins in human tissues
    K Pulford
    University Department of Cellular Science, John Radcliffe Hospital, Oxford, UK
    Blood 85:675-84. 1995

Detail Information

Publications63

  1. ncbi request reprint CD antigens 2001
    D Mason
    Haematology Department, John Radcliffe Hospital, Oxford, UK
    J Leukoc Biol 70:685-90. 2001
    ..This resulted in the addition of more than 80 new CD specificities. Plans for the eighth and subsequent workshops are also previewed...
  2. ncbi request reprint CD antigens 2001
    D Y Mason
    Haematology Department, Nuffield Dept of Clinical Laboratory Sciences, University of Oxford, Rm 4734 John Radcliffe Hospital, Oxford OX3 9DU, UK
    Tissue Antigens 58:425-30. 2001
    ....
  3. ncbi request reprint Innovations in immunohistochemistry for the haematopathologist
    D Y Mason
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Ann Pathol 27:1S33-6. 2007
  4. ncbi request reprint Reference: CD Antigens 2002
    David Mason
    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Immunol 168:2083-6. 2002
  5. ncbi request reprint CD Antigens 2001
    David Mason
    Haematology Department, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
    Mod Pathol 15:71-6. 2002
  6. ncbi request reprint Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma
    Giovanna Roncador
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre, Madrid, Spain
    Haematologica 92:1059-66. 2007
    ....
  7. ncbi request reprint CD25 is a marker for CD4+ thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25+ and CD25- subpopulations
    L A Stephens
    Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom
    J Immunol 165:3105-10. 2000
    ..Phenotypic analysis of human thymocytes showed the presence of CD25+ cells in the same proportions as in rat thymus. The possible developmental relationship between CD25+ and CD25- regulatory T cells is discussed...
  8. pmc Peripheral autoantigen induces regulatory T cells that prevent autoimmunity
    B Seddon
    Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom
    J Exp Med 189:877-82. 1999
    ..Taken together, these data indicate that it is the peripheral autoantigen itself that stimulates the generation of the appropriate regulatory cells from thymic emigrant precursors...
  9. pmc Lymphocyte-specific protein 1: a specific marker of human leucocytes
    K Pulford
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Oxford, UK
    Immunology 96:262-71. 1999
    ..As the anti-LSP1 reagent used in the present study recognizes a formalin-resistant epitope it should be of considerable value in the diagnosis of routinely fixed material...
  10. ncbi request reprint Expression of TAL-1 proteins in human tissues
    K Pulford
    University Department of Cellular Science, John Radcliffe Hospital, Oxford, UK
    Blood 85:675-84. 1995
    ..TAL-1 protein is undetectable in other cell types. These reagents may play an important role in the diagnosis of T-ALL and could also be used in the context of lymphoma diagnosis on routinely fixed material...
  11. ncbi request reprint Human CD4(+)CD25(+) thymocytes and peripheral T cells have immune suppressive activity in vitro
    L A Stephens
    Sir William Dunn School of Pathology, University of Oxford, Oxford, GB
    Eur J Immunol 31:1247-54. 2001
    ....
  12. pmc T-cell-mediated control of autoimmunity
    D Mason
    Sir William Dunn School of Pathology, Oxford, UK
    Arthritis Res 3:133-5. 2001
    ..One of these has been shown to depend on a particular subset of CD4+ T cells that appears to have evolved specifically for this protective role. These cells are termed regulatory T cells. This review summarises what is known about them...
  13. ncbi request reprint Deaggregated homologous immunoglobulin-peptide conjugates induce peptide-specific T cell nonresponsiveness in vivo
    B Seddon
    Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, GB
    Eur J Immunol 28:4313-24. 1998
    ..The ability to intervene in ongoing immune responses with such specificity may be useful therapeutically in control of autoimmunity or allergic responses to environmental antigens...
  14. ncbi request reprint Control of immune pathology by regulatory T cells
    D Mason
    MRC Cellular Immunology Unit Sir William Dunn School of Pathology University of Oxford Oxford OX1 3RE UK
    Curr Opin Immunol 10:649-55. 1998
    ..The recent work on the antigen specificity, generation and mode of action of T reg cells is also reviewed...
  15. ncbi request reprint Combined immunophenotyping and FISH identifies the involvement of B-cells in 5q- syndrome
    R J Jaju
    Leukaemia Research Fund Molecular Haematology Unit, Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Genes Chromosomes Cancer 29:276-80. 2000
    ..This result suggests that in some cases, MDS arises in a multipotent cell with a capacity to differentiate into both myeloid and lymphoid cells...
  16. ncbi request reprint Anaplastic lymphoma kinase proteins and malignancy
    K Pulford
    Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK
    Curr Opin Hematol 8:231-6. 2001
    ..Although ALK-positive lymphomas have a generally good prognosis, new therapeutic regimens are still needed for patients whose disease is refractory to conventional treatment...
  17. ncbi request reprint Jaw1/LRMP, a germinal centre-associated marker for the immunohistological study of B-cell lymphomas
    S Tedoldi
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, UK
    J Pathol 209:454-63. 2006
    ..Finally, the expression of Jaw1/LRMP in other types of lymphoma and in non-lymphoid tissues/tumours may be of interest in differential diagnosis and research...
  18. ncbi request reprint Immunohistochemical screening for oncogenic tyrosine kinase activation
    K Pulford
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Oxford OX3 9DU, U K
    J Pathol 187:588-93. 1999
    ....
  19. ncbi request reprint Immune response to the ALK oncogenic tyrosine kinase in patients with anaplastic large-cell lymphoma
    K Pulford
    Nuffield Department of Clinical Laboratory Sciences and the Department of Haematology, John Radcliffe Hospital, Oxford, UK
    Blood 96:1605-7. 2000
    ..The immunocytochemical technique for detecting anti-ALK activity is simple and semiquantative and may provide a means of detecting B-cell responses to other tumor-associated molecules. (Blood. 2000;96:1605-1607)..
  20. ncbi request reprint The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures
    L H Butler
    University Department of Cellular Science, John Radcliffe Hospital, Oxford, UK
    Blood 89:3361-70. 1997
    ..Thus, HRX is widely expressed in most cell types including hematopoietic cells, a finding that precludes an immunocytochemical approach for diagnosis of leukemias bearing 11q23 structural abnormalities...
  21. pmc The plasma cell associated antigen detectable by antibody VS38 is the p63 rough endoplasmic reticulum protein
    A H Banham
    University of Oxford, Department of Cellular Science, John Radcliffe Hospital, United Kingdom
    J Clin Pathol 50:485-9. 1997
    ..To characterise the 64 kDa intracellular antigen present on normal and neoplastic plasma cells detected by monoclonal antibody VS38 and by another antibody, MC186, of similar reactivity...
  22. ncbi request reprint Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation
    D Y Mason
    Leukemia Research Fund Immunodiagnostics Unit, John Radcliffe Hospital, Oxford, United Kingdom
    Cancer Res 58:1057-62. 1998
    ....
  23. ncbi request reprint Expression pattern of intracellular leukocyte-associated proteins in primary mediastinal B cell lymphoma
    T Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, UK
    Leukemia 19:856-61. 2005
    ....
  24. ncbi request reprint Double immunofluorescence labelling of routinely processed paraffin sections
    D Y Mason
    Leukaemia Research Fund Immunodiagnostics Unit, The Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Pathol 191:452-61. 2000
    ..Its establishment involves relatively minor expenditure and it may represent the optimal technical approach to the co-localization of pairs of antigens in routinely processed tissue samples...
  25. ncbi request reprint Identification of the CD85 antigen as ILT2, an inhibitory MHC class I receptor of the immunoglobulin superfamily
    A H Banham
    University of Oxford, Nuffield Department of Clinical Biochemistry and Cellular Science, John Radcliffe Hospital, Headington, United Kingdom
    J Leukoc Biol 65:841-5. 1999
    ..This was confirmed by showing that both of the original anti-CD85 mAbs stained ILT2 transfectants. The cell signaling role demonstrated for ILT2 is consistent with the previously reported involvement of CD85 in T cell activation...
  26. ncbi request reprint Some quantitative aspects of T-cell repertoire selection: the requirement for regulatory T cells
    D Mason
    Sir William Dunn School of Pathology, Oxford, UK
    Immunol Rev 182:80-8. 2001
    ..The potential value of regulatory T cells to the control of inflammation induced by pathogens is also briefly discussed...
  27. ncbi request reprint Rat interleukin-4 assays
    F Ramirez
    MRC Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, UK
    J Immunol Methods 221:141-50. 1998
    ..According to our experience, the bioassay based on the induction of class II MHC molecules on B cells is the technique of choice for rat IL-4 determination because it proved specific, sensitive and reproducible...
  28. ncbi request reprint Molecular cloning of ICAM-3, a third ligand for LFA-1, constitutively expressed on resting leukocytes
    J Fawcett
    ICRF Laboratories, University of Oxford, UK
    Nature 360:481-4. 1992
    ..ICAM-3 is closely related to ICAM-1, consists of five immunoglobulin domains, and binds LFA-1 through its two N-terminal domains...
  29. ncbi request reprint Loss of CD19 expression in B-cell neoplasms
    N Masir
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK
    Histopathology 48:239-46. 2006
    ..To investigate whether an antibody against an intracellular epitope can detect CD19 in routine biopsy specimens and thus to document in detail its expression in human lymphomas...
  30. pmc The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
    A Saoudi
    Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, United Kingdom
    J Exp Med 184:2393-8. 1996
    ....
  31. ncbi request reprint Induction of autoimmune disease by depletion of regulatory T cells
    S Simmonds
    University of Oxford, Oxford, United Kingdom
    Curr Protoc Immunol . 2001
    ..This unit describes the induction of insulin-dependent diabetes in the rat. A modified protocol allows for the induction of a more severe form of the disease...
  32. pmc Application of the FICTION technique for the simultaneous detection of immunophenotype and chromosomal abnormalities in routinely fixed, paraffin wax embedded bone marrow trephines
    P Korac
    Nuffield Department of Clinical Laboratory Sciences, University of Oxford, LRF Immunodiagnostics Unit, John Radcliffe Hospital, Headington, Oxford OX3 9DU, UK
    J Clin Pathol 58:1336-8. 2005
    ..The application of this to routine clinical practice will assist diagnosis and the detection of minimal residual disease...
  33. ncbi request reprint Characterisation of thymus-derived regulatory T cells that protect against organ-specific autoimmune disease
    L A Stephens
    Sir William Dunn School of Pathology, University of Oxford, South Parks Road, Oxford OX1 3RE, UK
    Microbes Infect 3:905-10. 2001
    ..Our own work on the origin, phenotypic characterisation and mode of action of these regulatory T cells in rats forms the main focus of this review...
  34. ncbi request reprint Tyrosine phosphorylation in human lymphomas
    E Haralambieva
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Histochem J 34:545-52. 2002
    ..We conclude that activation of a tyrosine kinase is probably not a major oncogenic event in lymphomas other than ALK-positive ALCL...
  35. pmc Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki67
    D C Brown
    Nuffield Department of Pathology, John Radcliffe Hospital, Headington, Oxford, UK
    Br J Cancer 57:178-81. 1988
    ..Immunostaining with monoclonal antibody Ki67 therefore provides a new approach to the assessment of cervical tumour biopsies which will require long term clinical follow-up to establish its prognostic significance...
  36. ncbi request reprint The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p
    A H Banham
    University of Oxford, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Headington, Oxford OX3 9DU, United Kingdom
    Cancer Res 61:8820-9. 2001
    ..Our study identifies FOXP1 as a new candidate tumor suppressor gene localized to the chromosome 3p14.1 region...
  37. pmc Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma
    F Pezzella
    Department of Haematology, John Radcliffe Hospital, Oxford, UK
    Br J Cancer 65:87-9. 1992
    ..Our results show that there are no grounds for considering either the 14;18 translocation or the expression of the bcl-2 protein to be useful prognostic markers in clinical practice...
  38. ncbi request reprint Immunochemical studies of antigenic lymphoma-associated proteins
    Karen Pulford
    Nuffield Department of Clinical Laboratory Sciences, Leukaemia Research Fund Immunodiagnostics Unit, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 116:135-41. 2002
    ..These results suggest a strategy for using patients' autoantibodies to screen for antibodies to other tumour-associated proteins...
  39. ncbi request reprint PRDM1/BLIMP-1 expression in multiple B and T-cell lymphoma
    Jose Francisco Garcia
    Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre CNIO, Madrid, Spain
    Haematologica 91:467-74. 2006
    ..The positive regulatory domain I (PRDM1) protein or BLIMP-1, belonging to the PRDM gene family of transcriptional repressors, is a key regulator of terminal differentiation in B-lymphocytes and is critical for plasma cell differentiation...
  40. pmc FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
    Roland A Ventura
    LRF Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom
    J Mol Diagn 8:141-51. 2006
    ..We hope that these suggestions will make FISH technology for the study of lymphoma biopsies more accessible to routine diagnostic and research laboratories...
  41. ncbi request reprint Proteins encoded by genes involved in chromosomal alterations in lymphoma and leukemia: clinical value of their detection by immunocytochemistry
    Brunangelo Falini
    Institute of Hematology, University of Perugia, Italy
    Blood 99:409-26. 2002
    ....
  42. ncbi request reprint The differential expression of LCK and BAFF-receptor and their role in apoptosis in human lymphomas
    Jennifer C Paterson
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Haematologica 91:772-80. 2006
    ..It was hypothesized that their expression patterns might yield information on apoptosis as it occurs in normal and reactive lymphoid cells, and also be of value for the detection of lymphoma subtypes...
  43. pmc The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas
    Yasodha Natkunam
    Department of Pathology, Stanford University School of Medicine, CA, USA, and Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 109:1636-42. 2007
    ..Our results warrant inclusion of LMO2 in multivariate analyses to construct a clinically applicable immunohistologic algorithm for predicting survival in patients with DLBCL...
  44. doi request reprint Labeling of multiple cell markers and mRNA using automated apparatus
    Jennifer C Paterson
    Leukaemia Research Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, University of Oxford, Oxford, UK
    Appl Immunohistochem Mol Morphol 16:371-81. 2008
    ..Finally, automated labeling could also be performed on peripheral blood and bone marrow smears, opening the possibility of using this procedure in the analysis of hematologic/cytology samples...
  45. ncbi request reprint Frequent epigenetic silencing of protocadherin 10 by methylation in multiple haematologic malignancies
    Jianming Ying
    Cancer Epigenetics Laboratory, Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong
    Br J Haematol 136:829-32. 2007
    ..Methylation was further detected in 14% of Hodgkin lymphoma sera. Thus, PCDH10 methylation is frequently involved in lymphomagenesis and could serve as a tumour-specific biomarker...
  46. pmc Detection of genetic alterations by immunoFISH analysis of whole cells extracted from routine biopsy material
    Goran Mattsson
    Haematology Department, Level 4, John Radcliffe Hospital, Oxford OX3 9DU, UK
    J Mol Diagn 9:479-89. 2007
    ..This procedure represents a novel methodology, which in some settings offers clear advantages over analysis of tissue sections...
  47. ncbi request reprint Novel markers of normal and neoplastic human plasmacytoid dendritic cells
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Blood 111:3778-92. 2008
    ....
  48. pmc Expression of B-lymphocyte-associated transcription factors in human T-cell neoplasms
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom
    Am J Pathol 162:861-71. 2003
    ....
  49. ncbi request reprint Transmembrane adaptor molecules: a new category of lymphoid-cell markers
    Sara Tedoldi
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom
    Blood 107:213-21. 2006
    ..These molecules represent a potentially important addition to the panel of immunophenotypic markers detectable in routine biopsies that can be used in hematopathologic studies...
  50. ncbi request reprint Detection by the fluorescence in situ hybridization technique of MYC translocations in paraffin-embedded lymphoma biopsy samples
    Eugenia Haralambieva
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford OX3 9DU, UK
    Br J Haematol 121:49-56. 2003
    ....
  51. ncbi request reprint Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford OX3 9DU, United Kingdom
    Blood 102:2868-76. 2003
    ..Studies in experimental animals should help to elucidate the role of these cells in the immune response...
  52. ncbi request reprint Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, United Kingdom
    Blood 103:188-93. 2004
    ..Furthermore, the clear difference in expression of signaling proteins between the 2 major subtypes of Hodgkin disease may be of diagnostic value...
  53. ncbi request reprint Detection of three common translocation breakpoints in non-Hodgkin's lymphomas by fluorescence in situ hybridization on routine paraffin-embedded tissue sections
    Eugenia Haralambieva
    Department of Pathology, Leiden University Medical Centre, Leiden, The Netherlands
    J Pathol 198:163-70. 2002
    ..The results indicate that small locus-specific probes can be used in FISH for regular detection of translocation breakpoints on routine paraffin tissue sections...
  54. ncbi request reprint Intracellular signalling molecules as immunohistochemical markers of normal and neoplastic human leucocytes in routine biopsy samples
    Michela Pozzobon
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 124:519-33. 2004
    ..The observation that a range of leucocyte signalling molecules can be detected in routine biopsies offers new possibilities for studying normal and neoplastic human white cells in diagnostic tissue samples...
  55. ncbi request reprint Immunofluorescent and FISH analysis of skin biopsies
    Sylke Gellrich
    Department of Dermatology, Venereology and Allergy, Medical Faculty, Humboldt University, Berlin, Germany
    Am J Dermatopathol 26:242-7. 2004
    ..In this review, we describe the technical aspects of immunofluorescent and FISH analysis of routine cutaneous biopsy samples...
  56. ncbi request reprint Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom
    Haematologica 89:957-64. 2004
    ..In this paper, we have evaluated the usefulness of the pan-leukocyte marker LSP1 and the transcription factor PU.1 for resolving such diagnostic problems...
  57. ncbi request reprint Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cells
    Noraidah Masir
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 127:335-43. 2004
    ..FCRL may therefore represent a novel marker for normal B cells (e.g. splenic marginal zone cells) and may also be useful as a potential marker of B-cell neoplasms...
  58. ncbi request reprint The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas
    Teresa Marafioti
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 128:333-42. 2005
    ..It would be of interest to correlate this feature with patterns of gene expression and also with prognosis, since it may identify a subset of human lymphoma that is distinct in its molecular and clinical features...
  59. ncbi request reprint Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease
    Teresa Marafioti
    Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, Oxford, UK
    Br J Haematol 120:671-8. 2003
    ....
  60. ncbi request reprint Prognostic immunohistologic markers in human tumors: why are so few used in clinical practice?
    Yasodha Natkunam
    Department of Pathology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Lab Invest 86:742-7. 2006
    ....
  61. ncbi request reprint Human Leucocyte Differentiation Antigen nomenclature: update on CD nomenclature. Report of IUIS/WHO Subcommittee
    Heddy Zola
    Child Health Research Institute and Department of Paediatrics, Women s and Children s Hospital, Adelaide University, Adelaide 5006, Australia
    J Immunol Methods 275:1-8. 2003
    ..The major features of the cellular expression patterns are summarised, and a LocusLink accession number provided to enable the reader to access more detailed information through http://www.ncbi.nlm.nih.gov/LocusLink...
  62. ncbi request reprint Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays
    Elias Campo
    Department of Pathology, Hospital Clinic, University of Barcelona, Barcelona, Spain
    Haematologica 90:292. 2005
  63. pmc Follicular lymphoma with trisomy 18 exhibiting loss of BCL-2 expression on transformation to a large cell lymphoma
    Noraidah Masir
    Leukaemia Research Fund Immunodiagnostics Unit, Nuffield Department of Clinical Laboratory Sciences, John Radcliffe Hospital, University of Oxford, Oxford, UK
    J Clin Pathol 60:1061-4. 2007